These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7526574)

  • 1. Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccine.
    Sawyer LA; McInnis J; Patel A; Horne AD; Albrecht P
    Vaccine; 1994 Jul; 12(9):851-6. PubMed ID: 7526574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) versus standard oral poliovirus vaccine (OPV) in Thai infants.
    Simasathien S; Migasena S; Beuvery C; van Steenis G; Samakoses R; Pitisuttitham P; Vesikari T
    Scand J Infect Dis; 1994; 26(6):731-8. PubMed ID: 7747098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.
    Kraan H; Ten Have R; van der Maas L; Kersten G; Amorij JP
    Vaccine; 2016 Aug; 34(38):4572-4578. PubMed ID: 27470209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
    Eskola J; Olander RM; Hovi T; Litmanen L; Peltola S; Käyhty H
    Lancet; 1996 Dec 21-28; 348(9043):1688-92. PubMed ID: 8973430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.
    Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA
    Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
    Singer C; Knauert F; Bushar G; Klutch M; Lundquist R; Quinnan GV
    J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults.
    Kovac M; Rathi N; Kuriyakose S; Hardt K; Schwarz TF
    Vaccine; 2015 May; 33(22):2594-601. PubMed ID: 25882172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants.
    Halperin SA; Davies HD; Barreto L; Guasparini R; Meekison W; Humphreys G; Eastwood BJ
    J Pediatr; 1997 Apr; 130(4):525-31. PubMed ID: 9108847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines.
    Faden H; Duffy L; Sun M; Shuff C
    J Infect Dis; 1993 Aug; 168(2):452-4. PubMed ID: 8335983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines.
    Ogra PL; Faden HS; Abraham R; Duffy LC; Sun M; Minor PD
    J Infect Dis; 1991 Jul; 164(1):191-4. PubMed ID: 1647422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination.
    Sutter RW; Pallansch MA; Sawyer LA; Cochi SL; Hadler SC
    Ann N Y Acad Sci; 1995 May; 754():289-99. PubMed ID: 7625665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic structure of poliovirus in inactivated vaccines.
    Ferguson M; Wood DJ; Minor PD
    J Gen Virol; 1993 Apr; 74 ( Pt 4)():685-90. PubMed ID: 7682250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
    Halperin SA; King J; Law B; Mills E; Willems P
    Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines.
    Zhaori G; Sun M; Faden HS; Ogra PL
    J Infect Dis; 1989 Jun; 159(6):1018-24. PubMed ID: 2470831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine.
    Halperin SA; Langley JM; Eastwood BJ
    Clin Infect Dis; 1996 Jan; 22(1):59-62. PubMed ID: 8824967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
    Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
    Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
    Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.
    Ogra PL
    Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.